Fewer studies on SINEs are available in renal cell cancer (RCC), but published data demonstrate growth inhibition achieved by SINE compounds through the increase of nuclear localization of p21 and p53 that ultimately induces cell apoptosis both in-vitro and in-vivo. This evidence concerns the gene TP53 and renal cell adenocarcinoma.